These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16639430)

  • 1. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
    Lederman MM; Offord RE; Hartley O
    Nat Rev Immunol; 2006 May; 6(5):371-82. PubMed ID: 16639430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting sexual transmission of HIV-1 infection.
    Shattock RJ; Moore JP
    Nat Rev Microbiol; 2003 Oct; 1(1):25-34. PubMed ID: 15040177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can microbicides prevent medical transmission in MSM? Vaginal microbicides will be used rectally.
    AIDS Alert; 2010 Dec; 25(12):135-6. PubMed ID: 21328809
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal microbicides.
    O'Brien RF
    Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of new HIV infections and interventions to limit HIV transmission.
    Buchbinder S
    Top HIV Med; 2009; 17(2):37-43. PubMed ID: 19401606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical microbicides: the time has come.
    Dhawan D; Keller M; Klotman ME
    AIDS Read; 2006 Mar; 16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed ID: 16538955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbicides: a new frontier in HIV prevention.
    McGowan I
    Biologicals; 2006 Dec; 34(4):241-55. PubMed ID: 17097303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in microbicide vaginal rings.
    Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
    Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine. Microbicide shuts the door on HIV.
    Cohen J
    Science; 2004 Oct; 306(5695):387. PubMed ID: 15486260
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of HIV disease: opportunities for new prevention interventions.
    Fauci AS
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S206-12. PubMed ID: 18190288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
    das Neves J; Amiji M; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.